Esperion Announces Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
Esperion (NASDAQ: ESPR) has granted 12,900 restricted stock units (RSUs) to four new employees under its 2017 Inducement Equity Incentive Plan. The RSUs will vest 25% on the one-year anniversary of the recipient's vesting commencement date, with the remaining 75% vesting in twelve equal quarterly installments thereafter. These grants are specifically designed as employment inducements for new hires who were not previously associated with Esperion, in accordance with NASDAQ Listing Rule 5635(c)(4). The vesting is contingent upon continued employment with Esperion.
Esperion (NASDAQ: ESPR) ha concesso 12.900 unità di azioni riservate (RSU) a quattro nuovi dipendenti nell'ambito del suo Piano di Incentivazione Patrimoniale per il 2017. Le RSU acquisiranno il 25% del loro valore al primo anniversario della data di inizio acquisizione del beneficiario, con il restante 75% che sarà acquisito in dodici rate trimestrali uguali successivamente. Questi incentivi sono specificamente progettati come indennizzi per l'assunzione di nuovi dipendenti che non erano precedentemente associati a Esperion, conformemente alla Regola di Quotazione NASDAQ 5635(c)(4). L'acquisizione è subordinata al mantenimento dell'impiego con Esperion.
Esperion (NASDAQ: ESPR) ha otorgado 12,900 unidades de acciones restringidas (RSUs) a cuatro nuevos empleados bajo su Plan de Incentivo de Capital por Inducción de 2017. Las RSUs se adquirirán en un 25% en el primer aniversario de la fecha de inicio de adquisición del beneficiario, y el 75% restante se adquirirá en doce cuotas trimestrales iguales a partir de entonces. Estas concesiones están diseñadas específicamente como incentivos laborales para nuevos empleados que no estaban asociados anteriormente con Esperion, de acuerdo con la Regla de Listado NASDAQ 5635(c)(4). La adquisición está sujeta a la continuidad del empleo con Esperion.
Esperion (NASDAQ: ESPR)는 2017년 유도 자본 인센티브 계획에 따라 12,900개의 제한 주식 단위(RSU)를 4명의 신입 직원에게 부여했습니다. RSU는 수령인의 취득 시작일 1주년 기념일에 25%가 취득되며, 나머지 75%는 이후 12회의 동일한 분기별 할부로 취득됩니다. 이러한 부여는 Esperion과 이전에 관련이 없었던 신입 직원에 대한 고용 유도책으로 특별히 설계되었습니다. 취득은 Esperion에서의 계속 고용에 달려 있습니다.
Esperion (NASDAQ: ESPR) a accordé 12 900 unités d'actions restreintes (RSU) à quatre nouveaux employés dans le cadre de son Plan d'Incitation au Capital de 2017. Les RSU deviendront acquises à 25 % à la première date d'anniversaire de début d'acquisition du bénéficiaire, le reste de 75 % étant acquis en douze versements trimestriels égaux par la suite. Ces attributions sont spécifiquement conçues comme des incitations à l'emploi pour les nouvelles recrues qui n'étaient pas auparavant associées à Esperion, en conformité avec la Règle de Cotation NASDAQ 5635(c)(4). L'acquisition est conditionnée à la continuité de l'emploi chez Esperion.
Esperion (NASDAQ: ESPR) hat 12.900 beschränkte Aktieneinheiten (RSUs) an vier neue Mitarbeiter im Rahmen seines Inducement Equity Incentive Plans von 2017 gewährt. Die RSUs werden zu 25% am einjährigen Jahrestag des Beginns der Erwerbsberechtigung des Empfängers erlangt, wobei die verbleibenden 75% in zwölf gleichen vierteljährlichen Raten danach erlangt werden. Diese Gewährungen sind speziell als Anreiz für neue Beschäftigte konzipiert, die zuvor nicht mit Esperion in Verbindung standen, gemäß der NASDAQ-Listing-Regel 5635(c)(4). Der Erwerb ist vom fortgesetzten Beschäftigungsverhältnis mit Esperion abhängig.
- None.
- None.
ANN ARBOR, Mich., Nov. 08, 2024 (GLOBE NEWSWIRE) -- Esperion (NASDAQ: ESPR) today announced that on November 7, 2024, the Company granted four new employees 12,900 restricted stock units (RSUs) under Esperion’s 2017 Inducement Equity Incentive Plan.
The 2017 Inducement Equity Incentive Plan is used exclusively for the grant of equity awards to individuals who were not previously an employee or non-employee director of Esperion (or following a bona fide period of non-employment), as an inducement material to such individual's entering into employment with Esperion, pursuant to Rule 5635(c)(4) of the NASDAQ Listing Rules.
Each RSU will vest and become exercisable as to 25 percent of the shares on the one-year anniversary of the recipient’s vesting commencement date and will vest and become exercisable as to the remaining 75 percent of the shares in twelve equal quarterly installments at the end of each quarter following such anniversary, in each case, subject to each such employee's continued employment with Esperion on such vesting dates. The RSUs are subject to the terms and conditions of Esperion’s 2017 Inducement Equity Incentive Plan, and the terms and conditions of the RSU agreement covering the grant.
Esperion Therapeutics
At Esperion, we discover, develop, and commercialize innovative medicines to help improve outcomes for patients with or at risk for cardiovascular and cardiometabolic diseases. The status quo is not meeting the health needs of millions of people with high cholesterol – that is why our team of passionate industry leaders is breaking through the barriers that prevent patients from reaching their goals. Providers are moving toward reducing LDL-cholesterol levels as low as possible, as soon as possible; we provide the next steps to help get patients there. Because when it comes to high cholesterol, getting to goal is not optional. It is our life’s work. For more information, visit esperion.com and esperionscience.com and follow us on Twitter at twitter.com/EsperionInc.
Esperion Contact Information:
Investors:
Alina Venezia
investorrelations@esperion.com
(734) 887-3903
Media:
Tiffany Aldrich
corporateteam@esperion.com
(616) 443-8438
FAQ
How many RSUs did Esperion (ESPR) grant to new employees in November 2024?
What is the vesting schedule for Esperion's (ESPR) November 2024 RSU grants?
Under which plan did Esperion (ESPR) issue its November 2024 inducement grants?
